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a b s t r a c t
We report the detection of one case of co-infection with influenza A(H1N1)pdm09 and B, occurred during
the 2012–2013 influenza season in Sicily. The dual infection was identified in a 18-year-old boy, who was
not covered by specific vaccination and who had no other pre-existing risk factors. He presented classical
symptoms of influenza-like illness developing no respiratory complications. A(H1N1)pdm09 viral concen-
tration was initially about 10-fold higher than B virus, whereas its clearance was more rapidly achieved
than in the case of B virus infection. Although influenza co-infection appears to be a rare event, a contin-
ued influenza surveillance activity is recommended, in order to evaluate diversity and evolution, but also
to support public health prevention measures.
! 2014 Elsevier B.V. All rights reserved.
1. Introduction
In Sicily, epidemiological and virological surveillance of
influenza is annually conducted as part of the nationwide active
sentinel surveillance coordinated by the National Institute of
Health (Istituto Superiore di Sanità – ISS) in Rome.
In this context, the incidence of medically attended influenza-
like illness (ILI) is monitored by a group of sentinel practitioners
(general practitioners and paediatricians) covering about 2% of
the general population, co-operated by a limited number of
hospital physicians, in order to collect, each influenza season,
combined clinical and virological information on circulating viral
strains from week 46 to week 17 of the following year.
It is well documented that influenza epidemics are commonly
caused by type A and B viruses, differing year by year because of
the alternance or co-circulation of types and subtypes such as
A(H1N1) and A(H3N2), and offering the opportunity for genetic
reassortment as a consequence of possible co-infection in human
population (Ju et al., 2010).
In contrast to the previous 3-year period, in which influenza A
clearly predominated, national data collected during 2012–2013
depicted an epidemiological scenario characterized by a significant
co-circulation of influenza type A and B viruses (42.3% vs. 57.7%,
respectively) [http://www.iss.it/binary/fluv/cont/Agg.Vir_2_5_13.
pdf]. Although co-infection with both influenza A and B viruses
appears to be a rare event (Falchi et al., 2008; Almajhdi and Ali,
2013), in this study we describe the detection of a single case of
co-infection caused by influenza A(H1N1)pdm09 and B viruses in
Sicily during the 2012–2013 influenza epidemic.
2. Materials and methods
From November 2012 to April 2013, 321 nasopharyngeal swabs
(Virocult, MWE Medical Wire, UK) were collected from patients
(53.1% males; median age 19 years, IQR 45 years) suffering from
an influenza-like illness and then analyzed at the Regional Refer-
ence Laboratory for Influenza Surveillance and Molecular
Characterization.
According to the Italian influenza network (INFLUNET) operat-
ing protocol [http://www.iss.it/binary/iflu/cont/Prot14.pdf], all
patients presented with typical symptoms of influenza, including
sudden onset of fever (P38 "C) plus at least one respiratory
symptom (cough, sore throat, rhinitis) and at least one systemic
symptom (headache, malaise, chills, asthenia). After getting an
informed consent from each patient or parents/guardians, all
swabs were collected and then immediately refrigerated at 4 "C
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for transport. Upon arrival, specimens were eluted in Dulbecco’s
Modified Eagle Medium (DMEM) and divided into aliquots for
molecular assays or stored at !80 "C for further analyses.
Extraction of viral RNA from 140 lL of clinical samples was
conducted using QIAamp Viral RNA Mini Kit (QIAGEN, Hilden,
Germany) according to manufacturer’s guidelines.
Detection of influenza A and B viruses, and housekeeping gene
RNase P was performed using the Superscript# III Platinum One-
Step qRT-PCR Kit (Life Technologies, Carlsbard, USA) on ABI Prism
7000 Real-Time PCR instrument (Applied Biosystems, Foster City,
CA) using specific primer and probe sets (Table S1). Positive and
negative controls were included in each real-time RT-PCR run.
The viral co-infection was confirmed using MDCK cells for influ-
enza virus propagation, performing both real-time RT-PCR and
one-step PCR amplifications on culture supernatant. Hemoaggluti-
nin (HA) and neuraminidase (NA) nucleotide sequences were
obtained from both A(H1N1)pdm09 and B co-infecting viruses by
direct sequencing (Fig. S1), using the BigDye terminator chemistry
version 3.1 (Applied Biosystems, Foster City, CA) according to the
instructions of the manufacturer.
Both HA and NA sequences were submitted to GenBankwith the
following accession numbers: KF700627, KF700628, KF700629,
KF700630.
The present work was reviewed and approved by the institu-
tional review board of the University Hospital ‘‘P. Giaccone’’ of Pa-
lermo (Sicily), health data were stored according to the Italian laws
on privacy, and the research was conducted following the Helsinki
declaration statements.
3. Results
In Sicily, the winter annual influenza outbreak began in January
and ended in March 2013 (Fig. 1). Overall, 159 out of 321 (49.5%)
samples tested positive for influenza, type A viruses were identi-
fied in 45 out of 159 positive samples (28.3%: A(H1N1)pdm09,
n = 42; A(H3N2), n = 2; A-untypable, n = 1), whereas influenza B
was detected in 113 out of 159 (71.1%); only one patient (0.6%)
exhibited a co-infection with A(H1N1)pdm09 and B.
Of note, type B viruses prevailed during the first half of the
epidemic season, whereas late in February a higher proportion of
influenza A(H1N1)pdm09 infections became evident (Fig. 2). About
one week before the breakpoint (52.6% type A and 47.4% type B,
respectively), it was detected the only case of influenza type A
and B co-infection here reported.
3.1. Clinical and virological data of co-infected patient
This dual infection was identified in a 18-year-old boy with no
influenza vaccination coverage and no history of travelling out of
Sicily during the winter season.
At the time of nasopharyngeal swabbing (February 25, 2013), he
was at the third day of classical ILI symptoms (rapid onset of fever
to 38.5–39.0 "C, myalgia, arthralgia, headache, and sore throat)
together with tonsillar hypertrophy; no other pathologic signs
were observed. The patient was treated with acetaminophen and,
after 5 days, fever continued to be high, decreasing to 37.0 "C on
March 5 (11 days from onset).
On March 7, fever totally disappeared, as well as headache,
myalgia, and sore throat, while the tonsillar hypertrophy persisted.
Finally, on March 8, the boy resumed his school activity.
After laboratory viral detection on February 25, in order to
monitor the evolution of the dual infection and the kinetic of viral
clearance, nasopharingeal swabbing was further performed until
viral negativization (Table 1). Interestingly, although the concen-
tration of A(H1N1)pdm09 virus was initially about 10-fold higher
than B virus, as displayed by the real time cycle threshold (Ct)
values (Ct = 31 vs. Ct = 34: A(H1N1)pdm09 and B, respectively), its
clearance was more rapidly achieved than in the case of B virus
infection, which persisted for about one-week more. The third
nasopharyngeal specimen (March 5, 2013) was negative for both
the viruses, as definitively confirmed with the fourth specimen
collected on March 9, 2013 (Table 1).
4. Discussion
Dual infection with influenza viruses represents an infrequent
event and, to date, only few papers have been published mainly
reporting A(H3N2) and B co-infections (Shimada et al., 2006; Toda
et al., 2006; Falchi et al., 2008; Eshaghi et al., 2009), with just
Fig. 1. Weekly distribution of influenza-like illness (n = 321) and influenza laboratory-confirmed (n = 159) cases in Sicily, November 2012–April 2013. The graph depicts the
weekly cumulative number of influenza-like illness and influenza laboratory-confirmed cases reported during the surveillance season 2012–2013.
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one case of co-infection attributed to influenza virus A(H1N1)
pdm09 and B (Calistri et al., 2011).
The factors that may be responsible for such virological event
are not yet clear. In fact, dual infections have been documented
among people of different age-groups and both in immunocompro-
mised patients, thus suggesting a potential role of the immunolog-
ical state of the host (Toda et al., 2006; Almajhdi and Ali, 2013), and
in ‘‘healthy’’ patients without clinical complications (Shimada
et al., 2006; Toda et al., 2006; Falchi et al., 2008; Ju et al., 2010),
as also described in the present paper. Moreover, the fact that most
clinical manifestations observed in dual infections are quite similar
to those of single infections, characterized by self-limiting mild
classical symptoms, does not support the hypothesis of an
association between co-infection and severity of disease.
According to other authors (Shimada et al., 2006), different
levels of influenza viral types were observed in the co-infected
clinical sample, with a predominance of influenza type A, although
in association with a more rapid viral clearance in respect to type
B. Even though this finding may reflect different replication
efficiency of influenza viruses (Shimada et al., 2006), the literature
is poorly represented on this topic and contrasting results have
also been recently reported (Calistri et al., 2011).
Finally, of note, our case of co-infection happened in an unusual
epidemiological context characterized by a very high circulation of
influenza B strains (71.1%), partially overlapped with an increasing
spread of influenza A strains. This could have played a role in the
occurence of dual infection but more data are needed to confirm
this observation.
In conclusion, although rare, the detection of influenza co-infec-
tion could still represent an underestimated phenomenon, either in
terms of social impact or clinical implications, and it surely
contributes as a potential source of multiple viral transmission to
susceptible individuals.
Of course, the main limit of the present study is the lack of
consecutive samples showing evidence of dual infection, which
certainly would have better characterized our findings.
Nevertheless, these considerations suggest a continued surveil-
lance activity of monitoring distribution, prevalences, and molecu-
lar characteristics of circulating influenza strains, in order to
evaluate their diversity and evolution, but also to develop and/or
optimize public health prevention and control strategies.
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